Azure Cell Therapies

CHF 40,000 for Azure Cell Therapies, Jaipur Robotics | Techstars '24, and Winduction AG. These three projects were selected at Venture Kick's second financial and entrepreneurial support stage. https://lnkd.in/dgmvdRQs   Meet the 3 winning startups and their founders:   Dr. Bilal Fares (Co-Founder and CEO), Lena Grollmus (Research Affiliate), Dr. Olivia Cattaneo, PhD (Science & Business Associate), Prof. Emi Nagoshi (Chair of the SAB), and Prof. Karl-Heinz Krause (Co-Founder & CSO) | Azure Cell Therapies - Regenerating Neurons to Defeat Parkinson’s Disease. https://lnkd.in/dZ32mwQX   Ermes Zamboni (CEO) and Nikhil Prakash (CTO) | Jaipur Robotics | Techstars '24 - AI-powered waste recognition technology for Waste-to-Energy plants. https://lnkd.in/dNUFBAdn   Sonam Bhuka (Co-Founder and COO) and Sylvain Fricker (Co-Founder and CTO) | Winduction AG - Enabling EVs to charge wirelessly while driving or standing. https://lnkd.in/drV4rAcd #VentureKick #SwissStartups

🎉Registrations are now OPEN for the 14th edition of the Startup Champions Seed Night!💡 EPFL Alumni, EPFL Startup Launchpad, and Venturelab are thrilled to invite you to one of the most exciting startup events of the year, taking place at the Forum Rolex on EPFL campus on Thursday, April 10, 2025! Join us for an evening where top entrepreneurs from EPFL and beyond will showcase their technologies in a live 90-second pitch competition. Engage with startup founders, angel investors, mentors and scientists, vote for your favorite startup, and network over an aperitif. 🎟️ Seats are limited to 500 attendees, secure your spot now: https://lnkd.in/eHwgaRHx Meet the 2025 Startup Pitching Teams: 🔹 Neurovia Bioelectronics - William Esposito 🔹 Badger - Roberto Trivelli 🔹 Verretex - Nour Halawani 🔹 Hikane - Antoine Perrin 🔹 Humbrela - Chems ZAIDI 🔹 Azure Cell Therapies - Bilal Fares 🔹 Luxtelligence - Mohammad J. Bereyhi 🔹 Digehealth - Nour Ghalia Abassi 🔹 Dyneo - Mael Perret 🔹 MoleSense - Gian Luca Barbruni, PhD   🔹 Healium - Moncef Assa 🔹 Ex Nunc Intelligence SA - Kyriaki Bongard 🔹 Bioscibex - Chloé Albietz 🔹 Roofscapes - Olivier Faber 🔹 Inkocell Therapeutics - Mathieu Girardin   🔹 Avenir - Jeremy Bensoussan 🔹 Juvion Life Sciences - Soumya (Som) Banerjee 🔹 MobiLysis - Manos Barmpounakis 🔹 Focus Technology - Amin D. 🔹 PAVE Space SA - Julie Böhning This event is kindly supported by: EY, ANDRE ROLAND S.A., Alpian Bank, Innovaud, Kellerhals Carrard #EPFLAlumni #EPFLStartups #Venturelab #SeedNight2025 #Innovation #Entrepreneurship

Meet Bilal Fares, CEO of Azure Cell Therapies, who is advancing regenerative medicine with next-generation cell therapies for Parkinson’s disease. Building on two decades of research at the University of Geneva, the company uses patented cell and genetic engineering to produce neurons from stem cells. These therapies are designed to be safe, scalable, and capable of delivering long-lasting, disease-modifying effects. Congratulations to the whole team for recently winning Venture Kick stage 2: Azure Cell Therapies: Co-founder & CEO Dr. Bilal Fares, Research Associate Lena Grollmus, Science & Business Associate Dr. Olivia Cattaneo, PhD, Chair of the SAB Prof. Emi Nagoshi, and Co-founder & CSO Prof. Karl Krause. Read more: https://lnkd.in/dgmvdRQs   #VentureKick #SwissStartups #Parkinson

Incredibly excited, humbled, and grateful to share that we’ve made it to the Top 15 of the prestigious W.A. De Vigier Stiftung Award 2025, just under a year into our journey of building Azure Cell Therapies! 🚀🎉   None of this would be possible without the brilliance and dedication of our stellar, growing team at Azure; Thank you Karl Krause, Emi Nagoshi, Olivia Cattaneo, PhD, and Lena Grollmus for your unwavering trust, steadfast  support, and inspiring passion that made this possible! A heartfelt thank you as well to our mentors, scientific advisors, and experts who have guided us over the past year, helping us shape our vision towards success.   A massive congrats to all the incredible startups that participated, and especially to those that made it to the Top 15! Looking forward to meaningful connections and potential collaborations to drive innovation and impact together.   Huge thanks to the W.A. De Vigier Stiftung Foundation, the jury members, and everyone who has supported us on this journey. The final selection is in May, and we’re beyond excited for the next stages ahead!   #DeVigier #Top15 #Milestone #Gratitude #Innovation #Entrepreneurship #AzureCellTherapies #Teamwork #Parkinsons #CellTherapy

🥁🥁🥁 Meet the Top 15! 🥁🥁🥁 We proudly present the 15 outstanding startups advancing to the next round in the race for up to five awards, each endowed with CHF 100K in non-dilutive funding! 🎉 These impressive innovators are pushing boundaries and shaping our future. In mid-May, after in-depth interviews with our jury and expert reviews, the field will narrow to 10. 👀 Stay tuned as we get closer to selecting this year’s winners! Mark your calendars for June 18, when we live stream the award ceremony on our website. The Top 15 are: Axmed, Precise Health SA, PAVE Space SA, CellX Biosolutions, Azure Cell Therapies, sallea, Flink Robotics, Visienco AG, New Roots AG, YQuantum LLC, Clee Medical, InTeeth, rrreefs, Ionic Wind, Alligator AG #SwissStartups #devigier #innovation #StartupCompetition

We’re Growing! Welcome Olivia Cattaneo, PhD & Lena Grollmus to Azure Cell Therapies!   We are thrilled to welcome two outstanding new members to the Azure Cell Therapies team!   🔹 Olivia Cattaneo, PhD, joins us as our new Science & Business Associate, bringing a unique blend of neuroscience research expertise and experience as a venture scout, along with a passion for scientific communication and entrepreneurship. Her dedication to translational research, combined with her joyful spirit, contagious enthusiasm, and boundless energy, all make her her a key player in shaping Azure’s next exciting stage of development across both research and business fronts!   🔹 Lena Grollmus, MSc joins us as Research Intern, bringing specialized expertise in molecular biology, stem cell biology, and genetic engineering, along with strong organizational skills and keen attention to detail. As part of her internship, Lena will provide valuable support to our cutting-edge research in next-generation cell therapies, and we are thrilled to embark on this journey with her!   We couldn’t be more excited to have Olivia and Lena on board as we push forward our mission to develop innovative cell therapies for Parkinson’s disease.   Welcome to the team, Azurians!     #WelcomeToTheTeam #TeamAzure #Azurians #CellTherapy #Parkinson’s #Biotech

Representing the best of Swiss-Indian innovation and entrepreneurship: applause for the glorious graduates of the AIT India 2024/2025 program - and cheers to the winners of the pitch competition: Bilal Fares of Azure Cell Therapies and Claudia Bigoni of SaisiR - Science for Rehabilitation win CHF 10'000 each! Meet the AIT India startups & entrepreneurs: 4baseCare (Kshitij Rishi): Transforming precision oncology, using advanced genomic solutions & nextgen digital technology Ai Health Highway (Satish S Jeevannavar): Next-gen smart stethoscope that helps you see the sound & detect anomalies with Ai/ML integration Azure Cell Therapies (Bilal Fares): Regenerating neurons to defeat Parkinson's disease BCellOne (Miguel Solsona): We democratize cell therapies using nanotechnology Brightank (Kevin TURANI-I-BELLOTO-I-Belloto): Ammonia catalyst for cleaner energy CareMother by Doto Health (Harshal Sonar): Simplifying pregnancy and new born monitoring. GENOMIKI SOLUTIONS (Deeksha Bhartiya): Unlock the potential of your genomics data with our advanced genome-informatics solutions and get actionable insights Impli (Heath Hartle): Developing a hormone monitoring implant for IVF Inveel (Barbara Horvath): High resolution printed robotic skin Myriad Optics (Fahradin Mujovi): Quick detection of bacterial pathogens in the food industry Next Big Innovation Labs® (Alok Medikepura Anil): Advance your discoveries with customised bioprinting solutions Onescope (Yannick Ormen): Pneumoscope: the shazam® for lungs Phorest (Serhii Shyshkanov): Manufacturing of Pharma Ingredients from Renewable Feedstock Rechargion Energy Private Limited (Vilas Shelke): Sustainable next-generation Na-ion and Li-S rechargeable batteries SaisiR - Science for Rehabilitation (Claudia Bigoni): Help patients regain independence with neurotechnologies SEPARATIC (Timur Ashirov,): Adsorptive membranes for direct carbon capture from the air About: The Academia-Industry Training (AIT) India program is designed to help young researchers and founders of science-based Swiss startups identify the commercial potential of their innovations while developing key entrepreneurial skills. The program - organized by Leading House South Asia at ZHAW Zurich University of Applied Sciences, Swissnex in India, Consulate General of Switzerland and Venturelab - included a week-long trip to India in November 2024 and a follow-up session in Switzerland in February 2025, facilitating exchanges between two dynamic innovation ecosystems. #AITindia #SwissStartups

We’re thrilled to share that Azure Cell Therapies has been accepted into Venturelab's flagship Venture Kick program as Stage 1 winner! 🎉 This important milestone provides us unique access to an unparalleled ecosystem of resources, financial support, and entrepreneurial expertise at Venture Kick, empowering us to accelerate Azure Cell Therapies’ journey towards its next stage of growth. A heartfelt thank you to the Venture Kick team and esteemed jury members for believing in our vision and supporting our mission to transform regenerative medicine for Parkinson’s disease. Stay tuned—we have more exciting announcements and opportunities coming very soon! Follow our page to join us on this journey! 👉 Azure Cell Therapies 👈

We’re incredibly grateful for our journey at MassChallenge Switzerland! Being accepted as a finalist into the program just one month after the inception of Azure Cell Therapies from +1,300 startups worldwide was an honor in itself. Now, as a Top-20 winner among 118 high-impact finalists, we are truly humbled! A heartfelt thank you to our outstanding MC mentors Patrick Pestalozzi, Yan Agalarov, Dmitry Kopelyanskiy, PhD, Donya Smida, Eric Rolland, Vincent Griffoul, Semira Altot, MSc Pharm, Francisco Blanco, Dr Pierre A. Morgon, PharmD, LL.M, MBA, Emmanuelle Ferrari, Natalia Schmid, and Biland Sadek for their invaluable guidance and support, which has truly accelerated our development over the past 4 months. Congrats to all finalists and to the many friendships forged throughout this unique program! A huge thank you to the MassChallenge Switzerland team for their exceptional support, and special thanks to reuteler & cie SA for sponsoring our award which will make a tremendous difference at this stage of our journey! #MassChallengeSwitzerland #AzureCellTherapies #SwissInnovation #Entrepreneurship

We’re excited to announce that Azure Cell Therapies has been selected as one of the Top 10 Swiss finalists in the India-AIT program for 2024! Out of 82 applicants, our innovative approach to cell therapies stood out, and we are proud to join this fantastic group of pioneering startups.   Special thanks to Venturelab, ZHAW Zurich University of Applied Sciences, and Swissnex in India, Consulate General of Switzerland for this fantastic opportunity, and for putting-together such a dynamic program ahead.   We look forward to collaborating with 9 Indian startups, connecting with global industry leaders, and exploring opportunities to scale our innovations in India in the coming months!